Salute e Benessere

GUERBET : 2024 revenue.

2024 revenueSolid growth momentum for the second year in a rowFull-year revenue: €841.1 million, with growth of 9.0% on a like-for-like basis and at CERThis performance was achieved thanks to strong momentum in the Americas (+20.5%) and Asia (+10.1%) and despite the contraction of activity in FranceDetails on the 2024 financial statementsExpected Restated EBITDA margin close to 14.9%Free cash flow expected to be slightly negativeSignificant improvement in financial...
Nasdaq GlobeNewswire
06/02/2025

Temperature Monitoring Systems Market to Hit USD 5.66 Billion by 2030 with 5.3%…

Browse in-depth TOC on 'Temperature Monitoring Systems Market' Browse in-depth TOC on 'Temperature Monitoring Systems Market' 437 - Tables 64 - Figures 417 - Pages Moreover, in recent years, the market players are also focusing on providing cost-effective temperature monitoring systems due to its growing demand amongst various end users in the market. Also, there is an increasing demand for temperature monitoring systems specially for cold storage monitoring in the emerging...
PR Newswire
06/02/2025

ClariMed Inc. Unveils State-of-the-Art Study Facility in UK, Advancing Human…

"This facility represents a significant advancement in our ability to conduct sophisticated usability studies," said Julian Dixon, Associate Director of Human Factors and Site Lead of the Cambridge, UK office. "The elevated observation area offers our clients unprecedented visibility into user interactions, while our enhanced recording capabilities and flexible study spaces allowing us to simulate various usage environments with exceptional fidelity." "This facility…
PR Newswire
06/02/2025

/C O R R E C T I O N -- Pure Land Foundation/

Given the central role that digital platforms play in the lives of younger people, the Pure Land Foundation has pivoted away from grant-making into direct digital advocacy, producing original content for YouTube and social media that aims to make ancient and Buddhism-inspired teachings more accessible to everyone, without any religious lens. Given the central role that digital platforms play in the lives of younger people, thePure Land Foundation has pivoted away from grant-making into...
PR Newswire
06/02/2025

Corti's First AId Report: Burnout levels challenge healthcare professionals'…

According to the research, burnout levels are challenging healthcare professionals' ability to deliver care to patients – 41 percent report monthly burnout, 77 percent report feeling overwhelmed in their roles, and 24 percent think about leaving their role weekly due to overwhelming workloads. 23 percent experience burnout every week, impacting decision-making and patient care quality, and 26 percent say burnout affects their ability to provide consistent follow-up care. According to the...
PR Newswire
06/02/2025

We must make ancient wisdom more accessible to Gen Z to if we want to solve the…

The foundation's mission emphasizes empowering individuals to reshape their internal responses to life's challenges, especially when external circumstances are beyond their control. Wang says that ancient philosophies inspired by the likes of Buddhism are infused with wisdom and lessons that are scientifically proven to be beneficial for mental health. But people assume them to be the preserve of Buddhists or those with a 'yoga mat' lifestyle. The foundation's mission emphasizes empowering...
PR Newswire
06/02/2025

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational…

View original content:https://www.prnewswire.co.uk/news-releases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15-investigational-daratumumab-biosimilar-expansion-in-europe-and-the-us-302370087.html View original content: https://www.prnewswire.co.uk/news-releases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15-investigational-daratumumab-biosimilar-expansion-in-europe-and-the-us-302370087.html
PR Newswire
06/02/2025

Stax Appoints Adam Thorpe as Managing Director to Lead EMEA Healthcare Vertical…

"Adam's appointment further demonstrates Stax's ability to attract top-tier industry leaders," said Paul Edwards, Global Practice Leader. "With over 20 years of experience advising investors and navigating the complexities of UK and European health and life sciences, Adam joins our world-class healthcare vertical as we continue to grow share on both sides of the Atlantic." "Adam's appointment further demonstrates Stax's ability to attract top-tier industry leaders,"…
PR Newswire
06/02/2025

Inizio accelerates growth with a trio of strategic leadership appointments

"Over the past 12 months, Colin has played a key role in shaping our enterprise commercial model and delivering impact through our connected suite of capabilities. The dramatic success that we saw in pharma clients seeking to connect the expertise across Inizio means we are scaling this model to support our clients at every pivotal milestone from discovery to post-launch." Paul Taaffe, CEO of Inizio, commented. "Over the past 12 months, Colin has played a key role in shaping our…
PR Newswire
06/02/2025

Vistin Pharma ASA: Invitation to Q4 2024 conference call

Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day at 08:30 CET. There will be a Q&A session following the management discussion.The conference call will be held in English.The fourth quarter conference call will be available via web and audio through the following access points: Webcast:https://edge.media-server...
Nasdaq GlobeNewswire
06/02/2025

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 6 February 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
06/02/2025

The View From the World's Largest Humanitarian Aid Hub - Dubai Humanitarian…

DUBAI, UAE, Feb. 6, 2025 /PRNewswire/ -- Dubai Humanitarian, the world's largest humanitarian aid hub, leading efforts to provide aid to those affected by the crisis in Gaza, has released data from the Humanitarian Logistics Databank that reveals more than $137million worth of humanitarian aid was distributed to 106 countries during 2024. DUBAI, UAE, Feb. 6, 2025 /PRNewswire/ -- Dubai Humanitarian, the world's largest humanitarian aid hub, leading efforts to provide aid to those...
PR Newswire
06/02/2025

Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation…

Serplulimab was originated by Henlius Biotech. In 2023, Henlius entered into a collaboration with Intas Pharmaceuticals, granting Intas exclusive rights to develop and commercialise serplulimab in over 50 countries across Europe and India. This latest approval covers all 27 EU member states as well as the European Economic Area countries, including Norway, Iceland, and Liechtenstein. Commercialisation in Europe will be led by Accord. Serplulimab was originated by Henlius Biotech. In 2023,...
PR Newswire
06/02/2025

U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary…

Manfred Rüdiger, Chief Executive Officer at Ariceum Therapeutics, said: "Receiving ODD for 225Ac-satoreotide is a recognition of its potential as a treatment option for patients with SCLC and an important regulatory milestone for Ariceum. The FDA's ODD will support our objective to accelerate the development of 225Ac-satoreotide through human trials to provide a potentially life-saving therapy to patients with limited alternatives." Manfred Rüdiger, Chief Executive Officer at…
PR Newswire
06/02/2025

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in…

Agreement drives continued patient access to four important therapies in Japan and KoreaStrengthens Essential Pharma and Clinigen's combined market presence in the JAPAC regionEgham, UK – 6th February 2025– Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, and Clinigen, the global specialty...
Nasdaq GlobeNewswire
06/02/2025

POLYTECH Health & Aesthetics Strengthens Its Presence in the Nordics

By strengthening its presence in the region, POLYTECH underscores its dedication to delivering superior service and expertise. Surgeons across the Nordics will now benefit from direct access to POLYTECH's differentiated product portfolio, including B-Lite®, the world's only lightweight breast implants, along with the highly regarded MESMO® and Microthane® implants, renowned for their innovation and quality. By strengthening its presence in the region, POLYTECH underscores its dedication to...
PR Newswire
06/02/2025

Implantica announces onboarding of the world-leading La Paz University Hospital…

Dr. Pablo Priego says, "It is exciting to be at the forefront of innovation in the surgical treatment of GERD and to make the RefluxStop™ procedure available to more patients. I've been seeking a surgical treatment for GERD that does not encircle the food passageway for many years, it's thrilling to finally have this cutting-edge procedure to offer my patients who were not candidates for the traditional anti-reflux surgeries in the past." Dr.Pablo Priegosays, "It is exciting to be…
PR Newswire
06/02/2025

Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results

Søren Tulstrup, President and CEO, Hansa Biopharma said, "2024 proved to be a transformative year for Hansa, marked by ongoing commercial success of IDEFIRIX® across Europe and the achievement of key pipeline milestones in our priority therapy areas – Autoimmune, Gene Therapy, and Transplantation. Importantly, 2024 IDEFIRIX product sales, excluding the impact of a 49.6 MSEK provision to account for retroactive price adjustments linked to successful special early access programs following…
PR Newswire
06/02/2025

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE…

Press Release Dijon, FRANCE, February 6,2025 –0730h (CET)– Crossject (ISIN: FR0011716265; Euronext Growth : ALCJ), a specialty pharma company developing medicines harnessing its unique, award-winning needle-free ZENEO® auto-injector to deliver life-saving medicines in emergency situations, today announces, in accordance with the agreement entered into with Heights in December 2024, the completion of the amendments of the terms and conditions of the bonds issued to an entity affiliated to...
Nasdaq GlobeNewswire
06/02/2025

GN Annual Report 2024: Strong growth in Hearing and Gaming offset by slight…

2024 highlightsGN delivered revenue of DKK 18.0 billion with organic revenue growth of 1%, as a result of 10% organic revenue growth in Hearing, -3% organic revenue growth in Enterprise, 7% organic revenue growth in Gaming, and -31% organic revenue growth in Consumer due to the wind-down Excluding the wind-down, Group organic revenue growth was 4%Reported EBITA of DKK 2.2 billion and a margin of 12% Free cash flow excluding M&A ended at DKK 1.1 billion leading to an adj...
Nasdaq GlobeNewswire
06/02/2025

IBA signs Proteus®ONE system contract with AIG in Hyderabad, India

Louvain-La-Neuve, Belgium, February 06, 2025 –IBA(Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a binding agreement with the Asian Institute of Gastroenterology (AIG) for the supply of a Proteus ® ONE 1compact proton therapy system to be located at the new Oncology Centre within AIG Hospitals' Gachibowli campus in...
Nasdaq GlobeNewswire
06/02/2025

St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services

The hospital's Medical Travel Program achieved an impressive overall score, with 95% of the standards evaluated in "Full Compliance." This reflects St. Luke's dedication to offering an exceptional experience for medical travelers. The hospital's Medical Travel Program achieved an impressive overall score, with 95% of the standards evaluated in "Full Compliance." This reflects St. Luke's dedication to offering an exceptional experience for medical travelers. This latest…
PR Newswire
06/02/2025

Global Biologics Drug Substance Manufacturing Market to Exhibit Growth at a CAGR…

Key Takeaways from the Biologics Drug Substance Manufacturing Market Report Key Takeaways from the Biologics Drug Substance Manufacturing Market Report To read more about the latest highlights related to the biologics drug substance manufacturing market, get a snapshot of the key highlights entailed in theGlobal Biologics Drug Substance Manufacturing Market Report Biologics Drug Substance Manufacturing Overview Biologics drug substance manufacturing is a highly complex and...
PR Newswire
05/02/2025

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a…

Developed by Argent BioPharma Limited, CannEpil® is an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure frequency and severity while minimizing psychoactive effects. After years of clinical development, CannEpil® is making waves in the UK as part of a movement to transform severe epilepsy treatment. Developed by Argent BioPharma Limited, CannEpil® is an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure...
PR Newswire
05/02/2025
Altri  Comunicati